Trial Profile
Irbesartan in hypertensive patients with left ventricular hypertrophy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms I-SELECT
- Sponsors Sanofi
- 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2008 Planned number of patients changed from 418 to 268 as reported by ClinicalTrials.gov.
- 10 Apr 2008 The expected completion date for this trial is now 1 Jan 2009 as reported by ClinicalTrials.gov.